Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-12
2011-07-12
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S405000, C546S309000, C548S255000, C548S341500, C548S376100, C549S356000
Reexamination Certificate
active
07977367
ABSTRACT:
The present invention provides Formula (1A) compoundsthat act as glucokinase activators; pharmaceutical compositions thereof; and methods of treating diseases, disorders, or conditions mediated by glucokinase. X, Y, Z, R1, R2, R3, and R4are as described herein.
REFERENCES:
patent: 2006/0058353 (2006-03-01), Mckerrecher et al.
patent: 1532980 (2005-05-01), None
patent: WO 0246173 (2002-06-01), None
patent: WO 2004 072066 (2004-08-01), None
patent: WO 2005 095418 (2005-10-01), None
patent: WO 2007 043638 (2007-04-01), None
patent: WO 2007 117995 (2007-10-01), None
Moller, D. E., “New drug targets for Type II diabetes and the metabolic syndrome,” Nature 414, pp. 821-827, 2001.
Sarabu et al., Expert Opinion on Therapeutic Patents, vol. 18, No. 7, Jul. 2008, pp. 759-768.
Benbow John William
Lou Jihong
Pfefferkorn Jeffrey Allen
Tu Meihua Mike
Kispert Jennifer A.
Pfizer Inc
Wichtowski John A.
Willis Douglas M
Wilson James O
LandOfFree
Substituted imidazole propanamide glucokinase activators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazole propanamide glucokinase activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazole propanamide glucokinase activators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2707104